Literature DB >> 19168893

Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.

Amir H Kashani1, Pearse A Keane, Laurie Dustin, Alexander C Walsh, Srinivas R Sadda.   

Abstract

PURPOSE: To use optical coherence tomography (OCT) to quantify intraretinal cystoid spaces (ICSs) and the outer nuclear layer (ONL) in patients with neovascular age-related macular degeneration (AMD) and to investigate the correlation of these parameters with visual acuity.
METHODS: StratusOCT (Carl Zeiss Meditec, Inc., Dublin, CA) images were collected from 53 patients receiving their initial treatment with intravitreous ranibizumab. Images were analyzed with custom software (OCTOR) that allows accurate manual segmentation of OCT B-scans and provides thickness/volume measurements of ICS, ONL, neurosensory retina, pigment epithelial detachments (PEDs), subretinal fluid (SRF), and subretinal tissue (SRT). Univariate and multivariate analyses were used to correlate OCT parameters with best corrected Snellen visual acuity. Reproducibility was assessed with weighted kappa statistics and intraclass correlation coefficients.
RESULTS: A multivariate linear regression model with adjusted R(2) showed that ONL volume and SRT thickness significantly correlated with Snellen visual acuity (R(2) = 0.15, P = 0.002 and R(2) = 0.19, P = 0.001, respectively) with an overall model R(2) of 0.34. Adjustment of ONL volume for ICS did not improve correlation with visual acuity, and ICS volume did not independently correlate with visual acuity. Weighted kappa statistics showed excellent intergrader agreement for both ICS and ONL measurements.
CONCLUSIONS: The results suggest that an increased total volume of the ONL is associated with decreased visual acuity in neovascular AMD and that the total volume of ICS does not correlate with visual acuity. Although the correlations detected in this study are modest, quantitative subanalysis of OCT images may be of greater clinical relevance in the context of more advanced OCT technology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168893      PMCID: PMC2908154          DOI: 10.1167/iovs.08-2691

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Tomographic findings of foveal hard exudates in diabetic macular edema.

Authors:  T Otani; S Kishi
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

2.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.

Authors:  Pascale Massin; Graham Duguid; Ali Erginay; Belkacem Haouchine; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

3.  Morphometric analysis of the macula in eyes with disciform age-related macular degeneration.

Authors:  S Y Kim; S Sadda; J Pearlman; M S Humayun; E de Juan; B M Melia; W R Green
Journal:  Retina       Date:  2002-08       Impact factor: 4.256

4.  Morphometric analysis of the macula in eyes with geographic atrophy due to age-related macular degeneration.

Authors:  S Y Kim; S Sadda; M S Humayun; E de Juan; B M Melia; W R Green
Journal:  Retina       Date:  2002-08       Impact factor: 4.256

5.  Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT).

Authors:  Winfried Goebel; Tatjana Kretzchmar-Gross
Journal:  Retina       Date:  2002-12       Impact factor: 4.256

6.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration.

Authors:  T Daniel Ting; Mila Oh; Terry A Cox; Carsten H Meyer; Cynthia A Toth
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.

Authors:  Irene Barbazetto; Amy Burdan; Neil M Bressler; Susan B Bressler; Laurie Haynes; Anastasios D Kapetanios; Julius Lukas; Karl Olsen; Michael Potter; Al Reaves; Philip Rosenfeld; Andrew P Schachat; H Andrew Strong; Andrea Wenkstern
Journal:  Arch Ophthalmol       Date:  2003-09

8.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

Authors:  Neil M Bressler; Susan B Bressler; Nathan G Congdon; Frederick L Ferris; David S Friedman; Ronald Klein; Anne S Lindblad; Roy C Milton; Johanna M Seddon
Journal:  Arch Ophthalmol       Date:  2003-11

9.  Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Sandra Liakopoulos; Karen T Chang; Mingwu Wang; Laurie Dustin; Alexander C Walsh; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2008-10-18       Impact factor: 12.079

10.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

Authors:  Pascale Massin; François Audren; Belkacem Haouchine; Ali Erginay; Jean-François Bergmann; Rym Benosman; Charles Caulin; Alain Gaudric
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

View more
  17 in total

1.  [Effect of intravitreal bevacizumab on pigment epithelial detachment in occult choroidal neovascularization].

Authors:  M Ruppenstein; T Ach; A Höh; S Dithmar
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

2.  Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiography.

Authors:  Yanling Ouyang; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-31       Impact factor: 4.799

3.  Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akio Oishi; Masataka Shimozono; Michiko Mandai; Masayuki Hata; Akihiro Nishida; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-12       Impact factor: 3.117

4.  Three-dimensional analysis of retinal layer texture: identification of fluid-filled regions in SD-OCT of the macula.

Authors:  Gwénolé Quellec; Kyungmoo Lee; Martin Dolejsi; Mona K Garvin; Michael D Abràmoff; Milan Sonka
Journal:  IEEE Trans Med Imaging       Date:  2010-04-01       Impact factor: 10.048

5.  Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.

Authors:  Justis P Ehlers; Atsuro Uchida; Ming Hu; Natalia Figueiredo; Peter K Kaiser; Jeffrey S Heier; David M Brown; David S Boyer; Diana V Do; Andrea Gibson; Namrata Saroj; Sunil K Srivastava
Journal:  Ophthalmol Retina       Date:  2019-07-06

6.  Three-dimensional segmentation of fluid-associated abnormalities in retinal OCT: probability constrained graph-search-graph-cut.

Authors:  Xinjian Chen; Meindert Niemeijer; Li Zhang; Kyungmoo Lee; Michael D Abramoff; Milan Sonka
Journal:  IEEE Trans Med Imaging       Date:  2012-03-19       Impact factor: 10.048

7.  Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Praveen J Patel; Yanling Ouyang; Fred K Chen; Felicia Ikeji; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

8.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26

9.  Different phenotypes of the appearance of the outer plexiform layer on optical coherence tomography.

Authors:  Yanling Ouyang; Alexander C Walsh; Pearse A Keane; Florian M Heussen; Rajeev K R Pappuru; Srinivas R Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-10       Impact factor: 3.117

10.  Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Florian M Heussen; Yanling Ouyang; Nils Mokwa; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda; Praveen J Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.